Please assess the completion status of the following clinical trial:

Trial Title: AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults ≥18 years of age with confirmed COVID-19 infection~* Patient must be able to complete consent and hold mask~* Baseline room air oxygen saturation \<94% or new supplemental oxygen requirement at presentation or patient on supplemental oxygen at baseline and requiring up-titration of oxygen setting~* Patient in negative pressure room~* Patient must have access to an internet-connected device~Exclusion Criteria:~* Tracheostomy~* History of pneumothorax or known bullous lung disease~* Recent cataract surgery~* Patient receiving NIV (Noninvasive Ventilation) or HFNC (High Flow Nasal Cannula)~* Patient receiving mechanical ventilation~* Delirium

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Device intervention (Type: ACTIVE_COMPARATOR): Intervention participants will receive the AirFLO2 device and training via video with reinforcement from the coordinator how to use and to self-apply it. Clinical data will be recorded before and after intervention. Questionnaires will be completed at baseline and at serial time points after intervention starts.
- Standard of Care- Control (Type: NO_INTERVENTION): Participants will receive standard of care, clinical data will be recorded. Baseline and end of study questionnaires will be performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).